These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Use of cabergoline to treat primary and secondary anestrus in dogs.
    Author: Gobello C, Castex G, Corrada Y.
    Journal: J Am Vet Med Assoc; 2002 Jun 01; 220(11):1653-4. PubMed ID: 12051504.
    Abstract:
    OBJECTIVE: To determine whether cabergoline would be safe and effective for induction of estrus in dogs with primary or secondary anestrus. DESIGN: Prospective case series. ANIMALS: 6 privately owned otherwise healthy pure-bred dogs with primary or secondary anestrus. PROCEDURE: Dogs were treated with cabergoline (5 microg/kg [2.3 microg/lb], p.o., q 24 h) until 2 days after the onset of proestrus. Follicular development was assessed by means of cytologic examination of vaginal smears; ovulation was assessed by measuring serum progesterone concentration 3 weeks after the onset of estrus. Five bitches were mated during behavioral estrus. RESULTS: All dogs had normal estrus periods, and all 5 dogs that were mated whelped normal litters. Mean duration of cabergoline treatment was 16 days. None of the dogs had any adverse effects associated with cabergoline administration. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that administration of cabergoline is safe and effective for treatment for primary and secondary anestrus in dogs.
    [Abstract] [Full Text] [Related] [New Search]